UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer-Calling Out the "Double Standard"

JAMA oncology, 2023-05, Vol.9 (5), p.617

2023

Link zum Volltext

Verfügbarkeit prüfen

Androgen‐deprivation therapy, dementia, and cognitive dysfunction in men with prostate cancer: How much smoke and how much fire?

Cancer, 2018-04, Vol.124 (7), p.1326-1334

2018

Link zum Volltext

Verfügbarkeit prüfen

Ototoxicity associated with high‐dose carboplatin for patients with previously treated germ cell tumors

Cancer, 2023-12, Vol.129 (24), p.3952-3961

2023

Link zum Volltext

Verfügbarkeit prüfen

Conventional-Dose versus High-Dose Chemotherapy for Relapsed Germ Cell Tumors

Advances in urology, 2018-01, Vol.2018, p.7272541-7

2018

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Chemotherapy With Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1332-1337

2020

Link zum Volltext

Verfügbarkeit prüfen

Management of Biochemically Recurrent Prostate Cancer: Ensuring the Right Treatment of the Right Patient at the Right Time

American Society of Clinical Oncology educational book, 2018-05, Vol.38 (38), p.355-362

2018

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Trial of IGF-1R Inhibitor Cixutumumab and mTOR Inhibitor Temsirolimus in Metastatic Castration-resistant Prostate Cancer

Clinical genitourinary cancer, 2020-06, Vol.18 (3), p.171-178.e2

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates

Journal of clinical oncology, 2022-07, Vol.40 (21), p.2333-2341

2022

Link zum Volltext

Verfügbarkeit prüfen

Craniocaudal nodal length (CCNL) as a risk-factor for relapse in stage I non-seminomatous germ cell tumors (NSGCT)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e17011-e17011

2022

Link zum Volltext

Verfügbarkeit prüfen

Reply to L.H. Einhorn et al

Journal of clinical oncology, 2020-09, Vol.38 (26), p.3074-3075

2020

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial

Journal of clinical oncology, 2022-04, Vol.40 (12), p.1312-1322

2022

Link zum Volltext

Verfügbarkeit prüfen

Defining germline genetics of germ cell tumor: Implications for genetic testing and clinical management

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5007-5007

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of talazoparib and avelumab in VHL deficient clear cell renal cell carcinoma

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.347-347

2022

Link zum Volltext

Verfügbarkeit prüfen

Outcomes After Multidisciplinary Management of Primary Mediastinal Germ Cell Tumors

Annals of surgery, 2021-12, Vol.274 (6), p.e1099

2021

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Updated results from a phase 2 trial

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4537-4537

2023

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel, ifosfamide & cisplatin (TIP) as second-line therapy for germ cell tumors (GCT):Long-term follow-up and expansion cohort

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.386-386

2021

Link zum Volltext

Verfügbarkeit prüfen

Enfortumab vedotin in FGFR3-mutated advanced urothelial carcinoma

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.458-458

2021

Link zum Volltext

Verfügbarkeit prüfen

Identifying germline genetic alterations or environmental factors associated with bilateral germ cell tumor (GCT)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5035-5035

2022

Link zum Volltext

Verfügbarkeit prüfen

Detailed evaluation of hearing loss (HL) associated with high-dose (HD) carboplatin for salvage treatment of germ cell tumors (GCT)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.401-401

2020

Link zum Volltext

Verfügbarkeit prüfen

CaMRA-B: Analysing the utility of cardiac magnetic resonance (CMR) imaging as an adjunct to conventional transthoracic echocardiography (TTE) in adjuvant breast cancers treated with anthracycline-based therapy, trastuzumab and left-sided irradiation

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e21560-e21560

2016

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Results of a phase 2 trial

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4509-4509

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunity to childhood vaccines following high dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) for germ cell tumors (GCT) with comparison to Hodgkin lymphoma (HL)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5017-5017

2021

Link zum Volltext

Verfügbarkeit prüfen

A Phase II, Nonrandomized Open Trial Assessing Pain Efficacy with Radium-223 in Symptomatic Metastatic Castration-resistant Prostate Cancer

Clinical genitourinary cancer, 2021-10, Vol.19 (5), p.447-456

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer

Investigational new drugs, 2019-10, Vol.37 (5), p.1052-1060

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Humans
(10)
Male
(9)
Oncology
(9)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(4)
Adolescent
(3)
Adult
(3)
Middle Aged
(3)
Neoplasms, Germ Cell And Embryonal - Drug Therapy
(3)
Original Reports
(3)
Prostate Cancer
(3)
Urology & Nephrology
(3)
Aged
(2)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)
Cancer
(2)
Cancer Treatment
(2)
Castration-Resistant
(2)
Chemotherapy
(2)
Chemotherapy, Adjuvant
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer-Calling Out the "Double Standard"

Androgen‐deprivation therapy, dementia, and cognitive dysfunction in men with prostate cancer: How much smoke and how much fire?

Ototoxicity associated with high‐dose carboplatin for patients with previously treated germ cell tumors

Conventional-Dose versus High-Dose Chemotherapy for Relapsed Germ Cell Tumors

Adjuvant Chemotherapy With Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors

Cabozantinib Plus Nivolumab in Patients with Non–Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial

Management of Biochemically Recurrent Prostate Cancer: Ensuring the Right Treatment of the Right Patient at the Right Time

A Phase I Trial of IGF-1R Inhibitor Cixutumumab and mTOR Inhibitor Temsirolimus in Metastatic Castration-resistant Prostate Cancer

Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates

Craniocaudal nodal length (CCNL) as a risk-factor for relapse in stage I non-seminomatous germ cell tumors (NSGCT)

Reply to L.H. Einhorn et al

Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial

Defining germline genetics of germ cell tumor: Implications for genetic testing and clinical management

A phase II study of talazoparib and avelumab in VHL deficient clear cell renal cell carcinoma

Outcomes After Multidisciplinary Management of Primary Mediastinal Germ Cell Tumors

Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Updated results from a phase 2 trial

Paclitaxel, ifosfamide & cisplatin (TIP) as second-line therapy for germ cell tumors (GCT):Long-term follow-up and expansion cohort

Enfortumab vedotin in FGFR3-mutated advanced urothelial carcinoma

Identifying germline genetic alterations or environmental factors associated with bilateral germ cell tumor (GCT)

Detailed evaluation of hearing loss (HL) associated with high-dose (HD) carboplatin for salvage treatment of germ cell tumors (GCT)

CaMRA-B: Analysing the utility of cardiac magnetic resonance (CMR) imaging as an adjunct to conventional transthoracic echocardiography (TTE) in adjuvant breast cancers treated with anthracycline-based therapy, trastuzumab and left-sided irradiation

Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Results of a phase 2 trial

Immunity to childhood vaccines following high dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) for germ cell tumors (GCT) with comparison to Hodgkin lymphoma (HL)

A Phase II, Nonrandomized Open Trial Assessing Pain Efficacy with Radium-223 in Symptomatic Metastatic Castration-resistant Prostate Cancer

A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer

Suchergebnisse filtern